Relationships between degradability of silk scaffolds and osteogenesis

Biomaterials

Volumn 31, Issue 24, 2010, Pages 6162-6172

  Park, Sang Hyug ^a   Gil, Eun Seok ^a   Shi, Hai ^a   Kim, Hyeon Joo ^a   Lee, Kyongbum ^a   Kaplan, David L ^a  

^a Tufts University   (United States)

Author keywords

Osteogenesis; Scaffold degradation; Silk; Stem cell metabolism; Tissue Regeneration

Indexed keywords

BIOMATERIAL SCAFFOLDS; BONE FORMATION; BONE REGENERATION; BONE REPAIR; BONE TISSUE FORMATION; CALCIUM CONTENT; CELL METABOLISM; CELLULAR METABOLISM; DEGRADABILITY; DEGRADATION RATE; GLUCOSE CONSUMPTION; HUMAN BONE MARROW DERIVED MESENCHYMAL STEM CELLS; IN-VITRO; MATRIX; METABOLIC ANALYSIS; OSTEOGENESIS; OSTEOGENIC; OVERALL RATE; RATIONAL DESIGN; REAL-TIME PCR; REGENERATIVE PROCESS; SCAFFOLD DEGRADATION; SEM; SILK SCAFFOLD; STEM CELL; TISSUE REGENERATION; TYPE I COLLAGEN;

BIOLOGICAL MATERIALS; BIOMATERIALS; BONE; CALCIUM; CELL CULTURE; DEGRADATION; GLUCOSE; METABOLISM; SILK; STEM CELLS;

SCAFFOLDS;

BIOMATERIAL; CALCIUM; COLLAGEN TYPE 1; GLUCOSE; LACTIC ACID; SILK FIBROIN; AMINO ACID; BIOLOGICAL MARKER; CULTURE MEDIUM; MESSENGER RNA; SILK;

ARTICLE; BONE DEVELOPMENT; BONE REGENERATION; BONE TISSUE; CELL METABOLISM; CHEMICAL ANALYSIS; CONTROLLED STUDY; EXTRACELLULAR MATRIX; GLUCOSE INTAKE; HEMATOPOIETIC STEM CELL; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO CULTURE; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SCANNING ELECTRON MICROSCOPY; ADULT; BIOLOGICAL MODEL; CELL CULTURE; CELL DIFFERENTIATION; CHEMISTRY; CULTURE MEDIUM; CYTOLOGY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STROMA CELL; METABOLISM; PHARMACOLOGY; TISSUE SCAFFOLD; ULTRASTRUCTURE;

ADULT; AMINO ACIDS; BIOLOGICAL MARKERS; CELL DIFFERENTIATION; CELLS, CULTURED; CULTURE MEDIA; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MESENCHYMAL STEM CELLS; MODELS, BIOLOGICAL; OSTEOGENESIS; RNA, MESSENGER; SILK; TISSUE SCAFFOLDS; MESENCHYMAL STROMAL CELLS;

EID: 77953649638     PISSN: 01429612     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2010.04.028     Document Type: Article

References (78)

1. Pham Q.P., Kasper F.K., Scott Baggett L., Raphael R.M., Jansen J.A., Mikos A.G. The influence of an in vitro generated bone-like extracellular matrix on osteoblastic gene expression of marrow stromal cells. Biomaterials 2008, 29:2729-2739.
2. Byrne E.M., Farrell E., McMahon L.A., Haugh M.G., O'Brien F.J., Campbell V.A., et al. Gene expression by marrow stromal cells in a porous collagen-glycosaminoglycan scaffold is affected by pore size and mechanical stimulation. J Mater Sci Mater Med 2008, 19:3455-3463.
3. Benoit D.S., Schwartz M.P., Durney A.R., Anseth K.S. Small functional groups for controlled differentiation of hydrogel-encapsulated human mesenchymal stem cells. Nat Mater 2008, 7:816-823.
4. Cartmell S. Controlled release scaffolds for bone tissue engineering. J Pharm Sci 2009, 98:430-441.
5. Drosse I., Volkmer E., Capanna R., De Biase P., Mutschler W., Schieker M. Tissue engineering for bone defect healing: an update on a multi-component approach. Injury 2008, 39(Suppl. 2):S9-S20.
6. Silva G.A., Coutinho O.P., Ducheyne P., Reis R.L. Materials in particulate form for tissue engineering. 2. Applications in bone. J Tissue Eng Regen Med 2007, 1:97-109.
7. Kim H.J., Kim U.J., Vunjak-Novakovic G., Min B.H., Kaplan D.L. Influence of macroporous protein scaffolds on bone tissue engineering from bone marrow stem cells. Biomaterials 2005, 26:4442-4452.
8. Wang Y., Rudym D.D., Walsh A., Abrahamsen L., Kim H.J., Kim H.S., et al. In vivo degradation of three-dimensional silk fibroin scaffolds. Biomaterials 2008, 29:3415-3428.
9. Abraham L.C., Dice J.F., Finn P.F., Mesires N.T., Lee K., Kaplan D.L. Extracellular matrix remodeling-methods to quantify cell-matrix interactions. Biomaterials 2007, 28:151-161.
10. Abraham L.C., Vorrasi J., Kaplan D.L. Impact of collagen structure on matrix trafficking by human fibroblasts. J Biomed Mater Res A 2004, 70:39-48.
11. Holtorf H.L., Jansen J.A., Mikos A.G. Ectopic bone formation in rat marrow stromal cell/titanium fiber mesh scaffold constructs: effect of initial cell phenotype. Biomaterials 2005, 26:6208-6216.
12. Leong D.T., Nah W.K., Gupta A., Hutmacher D.W., Woodruff M.A. The osteogenic differentiation of adipose tissue-derived precursor cells in a 3D scaffold/matrix environment. Curr Drug Discov Technol 2008, 5:319-327.
13. Sanz-Herrera J.A., Garcia-Aznar J.M., Doblare M. A mathematical approach to bone tissue engineering. Philos Transact A Math Phys Eng Sci 2009, 367:2055-2078.
14. Rezwan K., Chen Q.Z., Blaker J.J., Boccaccini A.R. Biodegradable and bioactive porous polymer/inorganic composite scaffolds for bone tissue engineering. Biomaterials 2006, 27:3413-3431.
15. Bakker A.D., Schrooten J., van Cleynenbreugel T., Vanlauwe J., Luyten J., Schepers E., et al. Quantitative screening of engineered implants in a long bone defect model in rabbits. Tissue Eng Part C Methods 2008, 14:251-260.
16. 3 scaffolds by poly(d, l-lactic acid) modification. Acta Biomater 2008, 4:343-353.
17. Navarro M., Michiardi A., Castano O., Planell J.A. Biomaterials in orthopaedics. J R Soc Interface 2008, 5:1137-1158.
18. Pollok J.M., Vacanti J.P. Tissue engineering. Semin Pediatr Surg 1996, 5:191-196.
19. Sanz-Herrera J.A., Garcia-Aznar J.M., Doblare M. On scaffold designing for bone regeneration: a computational multiscale approach. Acta Biomater 2009, 5:219-229.
20. Drury J.L., Mooney D.J. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 2003, 24:4337-4351.
21. Alsberg E., Kong H.J., Hirano Y., Smith M.K., Albeiruti A., Mooney D.J. Regulating bone formation via controlled scaffold degradation. J Dent Res 2003, 82:903-908.
22. Bryant S.J., Anseth K.S. Hydrogel properties influence ECM production by chondrocytes photoencapsulated in poly(ethylene glycol) hydrogels. J Biomed Mater Res 2002, 59:63-72.
23. Ge Z., Tian X., Heng B.C., Fan V., Yeo J.F., Cao T. Histological evaluation of osteogenesis of 3D-printed poly-lactic-co-glycolic acid (PLGA) scaffolds in a rabbit model. Biomed Mater 2009, 4:21001.
24. Kim H.J., Kim U.J., Kim H.S., Li C., Wada M., Leisk G.G., et al. Bone tissue engineering with premineralized silk scaffolds. Bone 2008, 42:1226-1234.
25. Kim H.J., Kim U.J., Leisk G.G., Bayan C., Georgakoudi I., Kaplan D.L. Bone regeneration on macroporous aqueous-derived silk 3-D scaffolds. Macromol Biosci 2007, 7:643-655.
26. Altman G.H., Diaz F., Jakuba C., Calabro T., Horan R.L., Chen J., et al. Silk-based biomaterials. Biomaterials 2003, 24:401-416.
27. Lee R.B., Urban J.P. Evidence for a negative Pasteur effect in articular cartilage. Biochem J 1997, 321:95-102.
28. Kim U.J., Park J., Kim H.J., Wada M., Kaplan D.L. Three-dimensional aqueous-derived biomaterial scaffolds from silk fibroin. Biomaterials 2005, 26:2775-2785.
29. Nazarov R., Jin H.J., Kaplan D.L. Porous 3-D scaffolds from regenerated silk fibroin. Biomacromolecules 2004, 5:718-726.
30. Park S.H., Park S.R., Chung S.I., Pai K.S., Min B.H. Tissue-engineered cartilage using fibrin/hyaluronan composite gel and its in vivo implantation. Artif Organs 2005, 29:838-845.
31. Trinder P. Determination of blood glucose using an oxidase-peroxidase system with a non-carcinogenic chromogen. J Clin Pathol 1969, 22:158-161.
32. Loomis M.E. An enzymatic fluorometric method for the determination of lactic acid in serum. J Lab Clin Med 1961, 57:966-969.
33. Lee K., Berthiaume F., Stephanopoulos G.N., Yarmush M.L. Profiling of dynamic changes in hypermetabolic livers. Biotechnol Bioeng 2003, 83:400-415.
34. Cohen S.A., De Antonis K.M. Applications of amino acid derivatization with 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate. Analysis of feed grains, intravenous solutions and glycoproteins. J Chromatogr A 1994, 661:25-34.
35. Imai Y., Takaoka K. The state and perspective in bone regeneration. Clin Calcium 2008, 18:1693-1700.
36. Ringe J., Kaps C., Burmester G.R., Sittinger M. Stem cells for regenerative medicine: advances in the engineering of tissues and organs. Naturwissenschaften 2002, 89:338-351.
37. Andermahr J., Elsner A., Brings A.E., Hensler T., Gerbershagen H., Jubel A. Reduced collagen degradation in polytraumas with traumatic brain injury causes enhanced osteogenesis. J Neurotrauma 2006, 23:708-720.
38. Uebersax L., Hagenmuller H., Hofmann S., Gruenblatt E., Muller R., Vunjak-Novakovic G., et al. Effect of scaffold design on bone morphology in vitro. Tissue Eng 2006, 12:3417-3429.
39. Lawrence B.D., Omenetto F., Chui K., Kaplan D.L. Processing methods to control silk fibroin film biomaterial features. J Mater Sci 2008, 43:6967-6985.
40. Piskin E. Biodegradable polymers as biomaterials. J Biomater Sci Polym Ed 1995, 6:775-795.
41. Li M., Ogiso M., Minoura N. Enzymatic degradation behavior of porous silk fibroin sheets. Biomaterials 2003, 24:357-365.
42. Kim W., Tretheway D.C., Kohles S.S. An inverse method for predicting tissue-level mechanics from cellular mechanical input. J Biomech 2009, 42:395-399.
43. Saha A.K., Mazumdar J.N. Dynamics of the cell and its extracellular matrix - a simple mathematical approach. IEEE Trans Nanobioscience 2003, 2:89-93.
44. Lian J.B., Stein G.S. Development of the osteoblast phenotype: molecular mechanisms mediating osteoblast growth and differentiation. Iowa Orthop J 1995, 15:118-140.
45. Stucki U., Schmid J., Hammerle C.F., Lang N.P. Temporal and local appearance of alkaline phosphatase activity in early stages of guided bone regeneration. A descriptive histochemical study in humans. Clin Oral Implants Res 2001, 12:121-127.
46. Lian J.B., Stein G.S. The developmental stages of osteoblast growth and differentiation exhibit selective responses of genes to growth factors (TGF beta 1) and hormones (vitamin D and glucocorticoids). J Oral Implantol 1993, 19:95-105. [discussion 136-7].
47. Kasugai S., Nagata T., Sodek J. Temporal studies on the tissue compartmentalization of bone sialoprotein (BSP), osteopontin (OPN), and SPARC protein during bone formation in vitro. J Cell Physiol 1992, 152:467-477.
48. Alford A.I., Hankenson K.D. Matricellular proteins: extracellular modulators of bone development, remodeling, and regeneration. Bone 2006, 38:749-757.
49. Giachelli C.M., Steitz S. Osteopontin: a versatile regulator of inflammation and biomineralization. Matrix Biol 2000, 19:615-622.
50. Ganss B., Kim R.H., Sodek J. Bone sialoprotein. Crit Rev Oral Biol Med 1999, 10:79-98.
51. Mischen B.T., Follmar K.E., Moyer K.E., Buehrer B., Olbrich K.C., Levin L.S., et al. Metabolic and functional characterization of human adipose-derived stem cells in tissue engineering. Plast Reconstr Surg 2008, 122:725-738.
52. Donzelli E., Salvade A., Mimo P., Vigano M., Morrone M., Papagna R., et al. Mesenchymal stem cells cultured on a collagen scaffold: in vitro osteogenic differentiation. Arch Oral Biol 2007, 52:64-73.
53. Shur I., Zilberman M., Benayahu D., Einav S. Adhesion molecule expression by osteogenic cells cultured on various biodegradable scaffolds. J Biomed Mater Res A 2005, 75:870-876.
54. Follmar K.E., Decroos F.C., Prichard H.L., Wang H.T., Erdmann D., Olbrich K.C. Effects of glutamine, glucose, and oxygen concentration on the metabolism and proliferation of rabbit adipose-derived stem cells. Tissue Eng 2006, 12:3525-3533.
55. Hwang D.Y., Ismail-Beigi F. Glucose uptake and lactate production in cells exposed to CoCl(2) and in cells overexpressing the Glut-1 glucose transporter. Arch Biochem Biophys 2002, 399:206-211.
56. Hediger M.A., Welbourne T.C. Introduction: glutamate transport, metabolism, and physiological responses. Am J Physiol 1999, 277:F477-F480.
57. Heywood H.K., Bader D.L., Lee D.A. Rate of oxygen consumption by isolated articular chondrocytes is sensitive to medium glucose concentration. J Cell Physiol 2006, 206:402-410.
58. Hirao M., Hashimoto J., Yamasaki N., Ando W., Tsuboi H., Myoui A., et al. Oxygen tension is an important mediator of the transformation of osteoblasts to osteocytes. J Bone Miner Metab 2007, 25:266-276.
59. Wan C., Gilbert S.R., Wang Y., Cao X., Shen X., Ramaswamy G., et al. Activation of the hypoxia-inducible factor-1alpha pathway accelerates bone regeneration. Proc Natl Acad Sci U S A 2008, 105:686-691.
60. Semenza G.L. Hypoxia-inducible factor 1: oxygen homeostasis and disease pathophysiology. Trends Mol Med 2001, 7:345-350.
61. Semenza G.L., Roth P.H., Fang H.M., Wang G.L. Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1. J Biol Chem 1994, 269:23757-23763.
62. Koukourakis M.I., Pitiakoudis M., Giatromanolaki A., Tsarouha A., Polychronidis A., Sivridis E., et al. Oxygen and glucose consumption in gastrointestinal adenocarcinomas: correlation with markers of hypoxia, acidity and anaerobic glycolysis. Cancer Sci 2006, 97:1056-1060.
63. Lehmann H.W., Bodo M., Frohn C., Nerlich A., Rimek D., Notbohm H., et al. Lysyl hydroxylation in collagens from hyperplastic callus and embryonic bones. Biochem J 1992, 282:313-318.
64. Myllyla R., Tryggvason K., Kivirikko K.I., Reddi A.H. Changes in intracellular enzymes of collagen biosynthesis during matrix-induced cartilage and bone development. Biochim Biophys Acta 1981, 674:238-245.
65. Phang J.M., Pandhare J., Liu Y. The metabolism of proline as microenvironmental stress substrate. J Nutr 2008, 138:2008S-2015S.
66. Bertolo R.F., Burrin D.G. Comparative aspects of tissue glutamine and proline metabolism. J Nutr 2008, 138:2032S-2039S.
67. Buckbinder L., Crawford D.T., Qi H., Ke H.Z., Olson L.M., Long K.R., et al. Proline-rich tyrosine kinase 2 regulates osteoprogenitor cells and bone formation, and offers an anabolic treatment approach for osteoporosis. Proc Natl Acad Sci U S A 2007, 104:10619-10624.
68. Smith R. Collagen and disorders of bone. Clin Sci (Lond) 1980, 59:215-223.
69. Tsuji N., Yoshikawa M., Shimomura Y., Yabuuchi T., Hayashi H., Ohgushi H. Osteogenic influence of lysine in porous hydroxyapatite scaffold. Key Eng Mater 2008, 361:1189-1192.
70. Diegelmann R.F. Analysis of collagen synthesis. Methods Mol Med 2003, 78:349-358.
71. Young M.F. Bone matrix proteins: more than markers. Calcif Tissue Int 2003, 72:2-4.
72. Mason D.J. Glutamate signalling and its potential application to tissue engineering of bone. Eur Cell Mater 2004, 7:12-25. [discussion 25-6].
73. Skerry T.M. The role of glutamate in the regulation of bone mass and architecture. J Musculoskelet Neuronal Interact 2008, 8:166-173.
74. Mazurek S., Eigenbrodt E., Failing K., Steinberg P. Alterations in the glycolytic and glutaminolytic pathways after malignant transformation of rat liver oval cells. J Cell Physiol 1999, 181:136-146.
75. Guarino V., Causa F., Ambrosio L. Bioactive scaffolds for bone and ligament tissue. Expert Rev Med Devices 2007, 4:405-418.
76. Yaszemski M.J., Payne R.G., Hayes W.C., Langer R., Mikos A.G. Evolution of bone transplantation: molecular, cellular and tissue strategies to engineer human bone. Biomaterials 1996, 17:175-185.
77. Knabe C., Berger G., Gildenhaar R., Meyer J., Howlett C.R., Markovic B., et al. Effect of rapidly resorbable calcium phosphates and a calcium phosphate bone cement on the expression of bone-related genes and proteins in vitro. J Biomed Mater Res A 2004, 69:145-154.
78. Knabe C., Berger G., Gildenhaar R., Howlett C.R., Markovic B., Zreiqat H. The functional expression of human bone-derived cells grown on rapidly resorbable calcium phosphate ceramics. Biomaterials 2004, 25:335-344.